Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript

Jun 03, 2021 / 02:00PM GMT
Release Date Price: €136.86 (+0.43%)
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst

Hi, everybody. I'm Lee Hambright, U.S. medical devices analyst at Bernstein. We are thrilled to host Johnson & Johnson this morning. Joining us virtually are Chairman and CEO, Alex Gorsky; and Vice Chairman, Joaquin Duato. We are scheduled for a 50-minute fireside chat.

(Operator Instructions)

So Alex and Joaquin, thanks so much for joining us. It's been a wild ride over the last 16 or 17 months for all of us, but I'm sure particularly extraordinary time to be the world's largest health care company. Alex, maybe you could just kick us off a bit with some opening remarks on the state of the business at J&J.

Alex Gorsky
Johnson & Johnson - Chairman & CEO

Sure, Lee. Well, first of all, thank you very much for having us today. I know Joaquin and I are both thrilled to be here with you. We're actually in our corporate headquarters here in New Brunswick, New Jersey, and we couldn't be happier to see our company, our leaders starting to come

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot